Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00523705 · ClinicalTrials.gov registry record · Phase 4
Escitalopram for Premenstrual Syndrome (PMS) in Teens: A Pilot Study
A Phase 4 study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT00523705: Clinical Trial Phase 4 study, sponsored by University of Pennsylvania.
NCT00523705 is a Phase 4 study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00523705, a Phase 4 study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to determine the efficacy and safety of escitalopram administered premenstrually (day 14 through day 2 of the menstrual cycle) for severe PMS in young women ages 15-19 years.
Interventions
- OTHER placebo
- DRUG escitalopram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00523705
The ClinicalTrials.gov registry entry for NCT00523705 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00523705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00523705 about?
NCT00523705 is a clinical study titled "Escitalopram for Premenstrual Syndrome (PMS) in Teens: A Pilot Study". The purpose of this pilot study is to determine the efficacy and safety of escitalopram administered premenstrually (day 14 through day 2 of the menstrual cycle) for severe PMS in young women ages 15-19 years.
What is the current status of trial NCT00523705?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2008-02. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00523705?
The interventions under investigation include: placebo (OTHER), escitalopram (DRUG).
Who is sponsoring clinical trial NCT00523705?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.